Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study

Autor: Federica Caminiti, Marcello Salvaggio, Federica Fusina, Marco Massari, Filippo Albani, Giuseppe Natalini, Manuela Baronio, M. E. Franceschetti, Barbara Faggian, Chiara Prezioso, Antonella Di Maio, Lilia Sepe

Publikováno v: EClinicalMedicine
Albani, F, Sepe, L, Fusina, F, Prezioso, C, Baronio, M, Caminiti, F, Di Maio, A, Faggian, B, Franceschetti, M E, Massari, M, Salvaggio, M & Natalini, G 2020, ' Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study ', EClinicalMedicine, vol. 27, pp. 100562 . https://doi.org/10.1016/j.eclinm.2020.100562
EClinicalMedicine, Vol 27, Iss, Pp 100562-(2020)
EClinicalMedicine, 27. Lancet Publishing Group

BACKGROUND: Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection is associated with hypercoagulability caused by direct invasion of endothelial cells and\or proinflammatory cytokine release. Thromboprophylaxis with enoxaparin is rec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::033cba77a7c47c2a40771de6463cf3a5
https://pubmed.ncbi.nlm.nih.gov/33043287